Chart A Category 5 Super Typhoon Is Tracking Toward 630 China and Taiwan Pharma Manufacturing Sites 8 July 2026
Expert Insight CMC Pharmaceuticals’ Mike Radomsky on the Mistakes That Kill Drug Programs 3 July 2026
Podcast Tariffs, FDA Chaos, and BioSecure in Limbo: How CDMOs Should Operate Under Uncertainty 28 June 2026
Chart China Now Sources 32% of Global Biopharma Out-Licensing Deals — Up from 5% in 2020 22 June 2026
